About the Department of Clinical Neuroscience
Welcome to the Department of Clinical Neuroscience at King's College London led by Professor Mark Richardson; Paul Getty III Professor of Epilepsy and Director of the Institute of Epileptology.
The Clinical Neuroscience Department is an internationally recognised centre of both research and teaching excellence that comprises of clinicians and scientists dedicated to improving the care of people with neurological disorders.
The nervous system is by far the most complex organ system in the body. The underlying disease mechanisms for many neurological conditions are poorly understood, and consequently there are very few effective treatments. Our mission is to better understand the underlying disease mechanisms so that we can develop and deliver more effective therapies.
Hosting the King's Health Partner's Centre for Neurodegeneration Research and MRC London Neurodegenerative Disease Brain Bank, we are exploring the causes of and cure for neurodegenerative conditions such as:
Alzheimer’s, fronto-temporal dementia,
Motor Neuron Disease.
We have a strong research team studying epilepsy, exploring research across a spectrum from laboratory to bedside; and we have research in stroke, brain and spinal cord injury, with an emphasis on prevention and acute intervention to enhance repair.
Our current research facilities will be greatly enhanced with the opening of the Wohl Clinical Neuroscience Institute
in 2013. This will provide cutting-edge technology for 250 researchers and students. We are driving research that will translate molecular discoveries made in the laboratory into therapies for our patients. There has never been a more exciting time to be involved in Cinical Neuroscience at King’s.
With these partners we run a successful programme of clinical trials in liaison with commercial pharmaceutical companies.